Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
4 "Jung Hwan Park"
Filter
Filter
Article type
Keywords
Publication year
Authors
Special Article
Adrenal gland
2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism
Jeonghoon Ha, Jung Hwan Park, Kyoung Jin Kim, Jung Hee Kim, Kyong Yeun Jung, Jeongmin Lee, Jong Han Choi, Seung Hun Lee, Namki Hong, Jung Soo Lim, Byung Kwan Park, Jung-Han Kim, Kyeong Cheon Jung, Jooyoung Cho, Mi-kyung Kim, Choon Hee Chung, The Committee of Clinical Practice Guideline of Korean Endocrine Society, The Korean Adrenal Study Group of Korean Endocrine Society
Endocrinol Metab. 2023;38(6):597-618.   Published online October 13, 2023
DOI: https://doi.org/10.3803/EnM.2023.1789
  • 40,704 View
  • 1,477 Download
  • 24 Web of Science
  • 26 Crossref
AbstractAbstract PDFPubReader   ePub   
Primary aldosteronism (PA) is a common, yet underdiagnosed cause of secondary hypertension. It is characterized by an overproduction of aldosterone, leading to hypertension and/or hypokalemia. Despite affecting between 5.9% and 34% of patients with hypertension, PA is frequently missed due to a lack of clinical awareness and systematic screening, which can result in significant cardiovascular complications. To address this, medical societies have developed clinical practice guidelines to improve the management of hypertension and PA. The Korean Endocrine Society, drawing on a wealth of research, has formulated new guidelines for PA. A task force has been established to prepare PA guidelines, which encompass epidemiology, pathophysiology, clinical presentation, diagnosis, treatment, and follow-up care. The Korean clinical guidelines for PA aim to deliver an evidence-based protocol for PA diagnosis, treatment, and patient monitoring. These guidelines are anticipated to ease the burden of this potentially curable condition.

Citations

Citations to this article as recorded by  
  • High Plasma Renin and Aldosterone Levels Are Associated With a Unique Phenotype in Primary Hypertension
    Jung Sun Cho, Ji-Hoon Jung, Woojin Kwon, Woo-Baek Chung, Sang Hyun Ihm
    Korean Circulation Journal.2026; 56(1): 49.     CrossRef
  • Risk of Hypertension and Chronic Kidney Disease Following Aldosterone Dysregulation
    Raymond R Townsend, Abiy Agiro, Shan Luan, Kaylen Brzozowski, Erick Moyneur, Paule Tetreault-Langlois, Joanna Huang
    American Journal of Hypertension.2026; 39(1): 161.     CrossRef
  • Evaluation of the MAGLUMI non-competitive angiotensin I chemiluminescence immunoassay for measuring renin activity in human plasma
    Lina Wu, Baohu Zhang, Yun Zhang, Shucai Yang, Chenyan Shi, Wenfeng Wang, Zhonggang Fang, Li Zhang, Xiaosong Qin
    Clinical Chemistry and Laboratory Medicine (CCLM).2026; 64(5): 1142.     CrossRef
  • Early-onset hypertension associated with a CACNA1H variant of uncertain significance: a case report and literature review
    Xiang Fang, Ruhui Liu, Jing Zeng
    BMC Cardiovascular Disorders.2026;[Epub]     CrossRef
  • Endocrine hypertension: the role of imaging in diagnosis and management
    Mohammed Azfar Siddiqui, Irfan Amir Kazi, Frank H Miller, Pardeep K Mittal, Esra Demirtas, Khaled M Elsayes, Ayman Nada
    British Journal of Radiology.2026; 99(1180): 733.     CrossRef
  • Evaluating simplified confirmation strategies for primary aldosteronism diagnosis
    Kangxin Cai, Qin Luo, Menghui Wang, Mulalibieke Heizhati, Huimin Ma, Weiwei Zhang, Gulinuer Duiyimuhan, Ayinigeer Abulimiti, Li Cai, Wen Jiang, Qing Zhu, Junli Hu, Ling Yao, Delian Zhang, Nanfang Li
    European Journal of Medical Research.2026;[Epub]     CrossRef
  • Primary Hyperaldosteronism: Epidemiology, Diagnosis, and Clinical Associations
    Christos Savvidis, Charalampos Milionis, Argyro Pachi, Athanasios Tselebis, Ioannis Ilias
    Epidemiologia.2026; 7(2): 32.     CrossRef
  • The Burden, Outcomes, and Management of Patients with Aldosterone Dysregulation: A Targeted Literature Review
    Gianfranco Parati, Gbenga Ogedegbe, Abiy Agiro, Shan Luan, Harrison Davis, Ian Daniel, Jan McKendrick, Joanna Huang, Raymond R. Townsend
    Advances in Therapy.2026; 43(5): 1926.     CrossRef
  • Aldosterone fuels the progression of cardiovascular-kidney -metabolic syndrome: focus on primary aldosteronism spectrum
    Huannan Wei, Xinyang Long, Mingli Li, Shengzhu Huang, Jianling Li, Zengnan Mo
    Endocrine.2026;[Epub]     CrossRef
  • A modifiable driver of dementia: cognitive impairment in primary aldosteronism
    Ying-Ying Zheng, Kai-Ge Feng, Xiang Xie
    Hypertension Research.2026; 49(8): 2386.     CrossRef
  • Ablation for Aldosterone-Producing versus Cortisol-Producing Adrenal Adenomas: A Comprehensive Review
    Byung Kwan Park, Jae Hyeon Kim, Young Lyun Oh, Jung-Han Kim
    Journal of Vascular and Interventional Radiology.2026; 37(9): 108894.     CrossRef
  • Association of the primary aldosteronism severity classification with lateralization and treatment outcomes
    Ju Hee Lee, Ha Young Kim, Min Jeong Park, A Ram Hong, Jeongmin Lee, Kyong Yeun Jung, Hyo-Jeong Kim, Eu Jeong Ku, Seung Shin Park, Seung Hun Lee, Jung Hee Kim
    The Journal of Clinical Endocrinology & Metabolism.2026;[Epub]     CrossRef
  • Interpretation of Diagnostic Testing for Primary Aldosteronism
    Eu Jeong Ku
    The Korean Journal of Medicine.2026; 101(4): 202.     CrossRef
  • Decision tree prediction of saline infusion test outcomes in suspected primary aldosteronism: a multicenter common data model study
    Kyoung Jin Kim, Jimi Choi, Namyoung Baek, Min Jeong Park, Eyun Song, So Young Park, Da Young Lee, Kyeong Jin Kim, Nam Hoon Kim, Hye Jin Yoo, Ji A Seo, Sin Gon Kim, Kyung Mook Choi, Nan Hee Kim, Ji Hee Yu
    The Journal of Clinical Endocrinology & Metabolism.2026;[Epub]     CrossRef
  • Differences in target organ damage between captopril challenge test-defined definitive-positive and borderline-range groups among patients with primary aldosteronism
    Naoki Fujiwara, Tatsuya Haze, Hiromichi Wakui, Kouichi Tamura, Mika Tsuiki, Kohei Kamemura, Daisuke Taura, Takamasa Ichijo, Yutaka Takahashi, Minemori Watanabe, Hiroki Kobayashi, Toshifumi Nakamura, Shoichiro Izawa, Norio Wada, Tetsuya Yamada, Kenichi Yok
    Hypertension Research.2025; 48(2): 540.     CrossRef
  • Major Adverse Cardiovascular Events in Primary Aldosteronism After Adrenalectomy or Mineralocorticoid Receptor Antagonist Treatment: A Systematic Review and Meta‐Analysis
    Chien‐Wei Huang, Tse‐Ying Huang, Ya‐Fei Yang, Li‐Yang Chang, Yu‐Kang Tu, Vin‐Cent Wu, Jui‐Yi Chen
    Journal of the American Heart Association.2025;[Epub]     CrossRef
  • Bridging Global and Local Perspectives on Primary Aldosteronism
    Ohk-Hyun Ryu
    Endocrinology and Metabolism.2025; 40(2): 195.     CrossRef
  • Subclassification of unilateral primary aldosteronism using an optimal cut-off value for positive CYP11B2 (aldosterone synthase) immunohistochemistry and modified histologic criteria in the Korean population
    Won Gi Hong, Byung-Chang Kim, Tae-Yon Sung, Seung Hun Lee, Dong Eun Song
    Human Pathology.2025; 163: 105876.     CrossRef
  • Correlation of Histopathologic Subtypes of Primary Aldosteronism with Clinical Phenotypes and Postsurgical Outcomes
    Chang Ho Ahn, You-Bin Lee, Jae Hyeon Kim, Young Lyun Oh, Jung Hee Kim, Kyeong Cheon Jung
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(8): e1582.     CrossRef
  • Temporal trends in clinical features of patients with primary aldosteronism over 20 years
    Seung Shin Park, Chang Ho Ahn, Sang Wan Kim, Jung-Min Koh, Seung Hun Lee, Jung Hee Kim
    Hypertension Research.2024; 47(8): 2019.     CrossRef
  • Primary aldosteronism: An underdiagnosed clinical entity
    Peeyush Jain, Atul Kaushik, Nilashish Dey, Ashwani Mehta, Shaloo Kapoor, Chhavi Agrawal
    Journal of Current Cardiology.2024; 2(2): 65.     CrossRef
  • Historical changes in the clinical features of primary aldosteronism
    Takamasa Ichijo
    Hypertension Research.2024; 47(10): 2926.     CrossRef
  • Comparing ARR Versus Suppressed PRA as Screening Tests for Primary Aldosteronism
    Marco Marcelli, Caixia Bi, John W. Funder, Michael J. McPhaul
    Hypertension.2024; 81(10): 2072.     CrossRef
  • Screening and treatment of endocrine hypertension focusing on adrenal gland disorders: a narrative review
    Seung Min Chung
    Journal of Yeungnam Medical Science.2024; 41(4): 269.     CrossRef
  • Diagnostic efficacy of aldosterone-to-renin ratio to screen primary aldosteronism in hypertension: a systemic review and meta-analysis
    Ting-Wei Kao, Jui-Yi Chen, Jung-Hua Liu, Wen-Hsin Tseng, Chih-Chia Hsieh, Vin-Cent Wu, Yen-Hung Lin, Zheng-Wei Chen
    Therapeutic Advances in Endocrinology and Metabolism.2024;[Epub]     CrossRef
  • Comparative Analysis of Liquid Chromatography-Tandem Mass Spectrometry and Radioimmunoassay in Determining Plasma Aldosterone Concentration and Plasma Renin Activity for Primary Aldosteronism Screening
    So Yoon Kwon, Kyeong-Jin Kim, Soo-Youn Lee, Jae Hyeon Kim
    Endocrinology and Metabolism.2024; 39(6): 965.     CrossRef
Close layer
Original Article
Thyroid
Associations between Hashimoto Thyroiditis and Clinical Outcomes of Papillary Thyroid Cancer: A Meta-Analysis of Observational Studies
Shinje Moon, Hye Soo Chung, Jae Myung Yu, Hyung Joon Yoo, Jung Hwan Park, Dong Sun Kim, Young Joo Park
Endocrinol Metab. 2018;33(4):473-484.   Published online November 30, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.4.473
  • 17,180 View
  • 154 Download
  • 76 Web of Science
  • 76 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Epidemiological studies have suggested an association between Hashimoto thyroiditis (HT) and papillary thyroid cancer (PTC) development. Other studies, however, have reported a protective role of HT against PTC progression. Through this updated meta-analysis, we aimed to clarify the effects of HT on the progression of PTC.

Methods

We searched citation databases, including PubMed and Embase, for relevant studies from inception to September 2017. From these studies, we calculated the pooled odds ratios (ORs) of clinicopathologic features and the relative risk (RR) of PTC recurrence with 95% confidence intervals (CIs) using the Mantel-Haenszel method. Additionally, the Higgins I2 statistic was used to test for heterogeneity.

Results

The meta-analysis included 71 published studies with 44,034 participants, among whom 11,132 had HT. We observed negative associations between PTC with comorbid HT and extrathyroidal extension (OR, 0.74; 95% CI, 0.68 to 0.81), lymph node metastasis (OR, 0.82; 95% CI, 0.72 to 0.94), distant metastasis (OR, 0.49; 95% CI, 0.32 to 0.76), and recurrence (RR, 0.50; 95% CI, 0.41 to 0.61).

Conclusion

In this meta-analysis, PTC patients with HT appeared to exhibit more favorable clinicopathologic characteristics and a better prognosis than those without HT.

Citations

Citations to this article as recorded by  
  • Impact of Hashimoto Thyroiditis on Long-Term Outcomes in Differentiated Thyroid Carcinoma
    Jasna Mihailović, Ivana Starčević, Slađana Novković-Ostojić, Tijana Vasiljević, Nataša Prvulović Bunović, Bojana Šćepanović
    Cancers.2026; 18(12): 1938.     CrossRef
  • Coexistent Hashimoto’s thyroiditis modulates lymph node metastasis burden in papillary thyroid carcinoma: a single-center study in South China
    Tianyu Gan, Dongyuan Gan, Guansheng Liao
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Hashimoto’s thyroiditis both promotes and protects against papillary thyroid cancer
    Xin Lin, Zhi Chen, Dandan Song, Jie Shen
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Clinicopathological predictors of radioiodine response in differentiated high-grade thyroid carcinoma
    Sohini Banerjee, Uma Nahar Saikia, Apurva Sood, Piyush Aggarwal, Soham Mukherjee, Pinaki Dutta, Divya Dahiya, Rijuneeta Gupta, Satyawati Mohindra, Jaimanti Bakshi
    Annals of Diagnostic Pathology.2026; : 152710.     CrossRef
  • Impact of chronic lymphocytic thyroiditis on the diagnostic and intraoperative management of papillary thyroid cancer
    Tanaz M. Vaghaiwalla, Victoria DeTrolio, Cima Saghira, Mehmet Akcin, Cheng-Bang Chen, Christel M. McGillicuddy, John I. Lew
    Surgery.2025; 179: 108937.     CrossRef
  • Investigating the Association Between Hashimoto's Thyroiditis and Papillary Thyroid Cancer
    Adriana I. Báez Berríos, Mathilda Monaghan, Margaret Brandwein‐Weber, Maaike van Gerwen
    Head & Neck.2025; 47(4): 1214.     CrossRef
  • Papillary thyroid carcinoma with Hashimoto’s thyroiditis: impact and correlation
    Shengpeng Yao, Hong Zhang
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • The effect of the presence of Hashimoto’s thyroiditis on the frequency of papillary thyroid carcinoma subtypes
    Zekiye Büşra Şahin, Zeynel Abidin Sayiner, Ersin Akarsu
    Folia Medica.2025;[Epub]     CrossRef
  • Bioinformatic analysis of serpina1 expression in papillary thyroid carcinoma and its potential association with Hashimoto's thyroiditis
    Xiuyuan Du, Wanjun Chen
    Discover Oncology.2025;[Epub]     CrossRef
  • Chronic Lymphocytic Thyroiditis Does Not Worsen Early Surgical Outcomes in Papillary Thyroid Cancer
    Tanaz M. Vaghaiwalla, Jonathan Chang, Victoria DeTrolio, Cima Saghira, Mehmet Akcin, Cheng‐Bang Chen, John I. Lew
    World Journal of Surgery.2025; 49(9): 2457.     CrossRef
  • Preoperative Clinical Factors Associated With High-Risk Features Predictive of Papillary Thyroid Cancer Recurrence
    Jonathan J. Chang, Nora E. Siegler, Elliott M. Henriksen, Cima Saghira, John I. Lew, Tanaz M. Vaghaiwalla
    Journal of Surgical Research.2025; 315: 900.     CrossRef
  • Malignancy risk of indeterminate lymph node at the central compartment in patients with thyroid cancer and concomitant sonographic thyroiditis
    Jung Hyo Rhim, Ji Ye Lee, Sun‐Won Park, Younghen Lee, So Lyung Jung, Tae Jin Yun, Eun Ju Ha, Jung Hwan Baek, Jinna Kim, Dong Gyu Na, Ji‐hoon Kim
    Head & Neck.2024; 46(8): 1922.     CrossRef
  • Hashimoto Thyroiditis and Mortality in Patients with Differentiated Thyroid Cancer: The National Epidemiologic Survey of Thyroid Cancer in Korea and Meta-Analysis
    Injung Yang, Jae Myung Yu, Hye Soo Chung, Yoon Jung Kim, Yong Kyun Roh, Min Kyu Choi, Sung-ho Park, Young Joo Park, Shinje Moon
    Endocrinology and Metabolism.2024; 39(1): 140.     CrossRef
  • Interaction of BANCR in the relationship between Hashimoto’s thyroiditis and papillary thyroid carcinoma expression patterns and possible molecular mechanisms
    Jiabo Zhang, Lingli Yao, Yu Guo
    The Journal of Gene Medicine.2024;[Epub]     CrossRef
  • Association between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis
    Jie Liu
    Clinical Thyroidology®.2024; 36(1): 26.     CrossRef
  • Predicting central cervical lymph node metastasis in papillary thyroid carcinoma with Hashimoto’s thyroiditis: a practical nomogram based on retrospective study
    Lirong Wang, Lin Zhang, Dan Wang, Jiawen Chen, Wenxiu Su, Lei Sun, Jue Jiang, Juan Wang, Qi Zhou
    PeerJ.2024; 12: e17108.     CrossRef
  • Nomogram to predict central lymph node metastasis in papillary thyroid carcinoma
    Dehui Qiao, Xian Deng, Ruichen Liang, Xu Li, Rongjia Zhang, Zhi Lei, Hui Yang, Xiangyu Zhou
    Clinical & Experimental Metastasis.2024; 41(5): 613.     CrossRef
  • Utilizing Immunoglobulin G4 Immunohistochemistry for Risk Stratification in Patients with Papillary Thyroid Carcinoma Associated with Hashimoto Thyroiditis
    Faridul Haq, Gyeongsin Park, Sora Jeon, Mitsuyoshi Hirokawa, Chan Kwon Jung
    Endocrinology and Metabolism.2024; 39(3): 468.     CrossRef
  • Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules 2024
    Young Joo Park, Eun Kyung Lee, Young Shin Song, Su Hwan Kang, Bon Seok Koo, Sun Wook Kim, Dong Gyu Na, Seung-Kuk Baek, So Won Oh, Min Kyoung Lee, Sang-Woo Lee, Young Ah Lee, Yong Sang Lee, Ji Ye Lee, Dong-Jun Lim, Leehi Joo, Yuh-Seog Jung, Chan Kwon Jung,
    International Journal of Thyroidology.2024; 17(1): 208.     CrossRef
  • Predictors of lateral lymph node metastasis and skip metastasis in patients with papillary thyroid microcarcinoma
    Jee Hee Yoon, Ji Yong Park, A Ram Hong, Hee Kyung Kim, Ho-Cheol Kang
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Surgical management of papillary thyroid carcinoma coexisting with Hashimoto’s disease: a single-center retrospective cohort study
    Dongdong Zhang, Jixiang Wu, Lin Chen
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Evaluating the Influence of Hashimoto’s Thyroiditis on Clinico‐Pathological Characteristics and Prognostic Outcomes of Middle Eastern Differentiated Thyroid Carcinoma
    Sandeep Kumar Parvathareddy, Abdul K. Siraj, Nabil Siraj, Saeeda O. Ahmed, Saif S. Al-Sobhi, Fouad Al-Dayel, Khawla S. Al-Kuraya, Henrik Falhammar
    International Journal of Endocrinology.2024;[Epub]     CrossRef
  • Chronic Lymphocytic Thyroiditis is a Protective Factor for Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Propensity Score Matching Analysis
    Jian Yu, Xiaoyang Li, Zhijian He, Jie He, Shangrui Rao
    British Journal of Hospital Medicine.2024; : 1.     CrossRef
  • Clinicopathological and molecular markers for the identification of Hashimoto’s thyroiditis as a possible predisposing and prognostic factor of papillary thyroid carcinoma
    Stavroula Daskalaki, Georgia Kafiri, Maria Venetikou, Apostolos Beloukas, Athina Kladi-Skandali, Fragkiski Anthouli-Anagnostopoulou
    Epitheorese Klinikes Farmakologias kai Farmakokinetikes – Greek Edition.2024; 42(2-3): 43.     CrossRef
  • Biomarkers associated with papillary thyroid carcinoma and Hashimoto’s thyroiditis: Bioinformatic analysis and experimental validation
    Bingxin Li, Zhaogen Cai, Yihan Zhang, Ruihua Chen, Shanshan Tang, Feijuan Kong, Wen Li, Li Ding, Lei Chen, Huanbai Xu
    International Immunopharmacology.2024; 143: 113532.     CrossRef
  • Risk prediction for central lymph node metastasis in isolated isthmic papillary thyroid carcinoma by nomogram: A retrospective study from 2010 to 2021
    Yu Zhao, Wei Shi, Fang Dong, Xiuhua Wang, Chong Lu, Chunping Liu
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • The evaluation of locoregional tumoral involvement in the cooccurrence of hashimoto thyroiditis with papillary thyroid cancer: a case controlled study
    Shirzad Nasiri, Seyed Mostafa Meshkati Yazd, Mahsa Gholami, Sepehr Shahriarirad, Sina Sharghi, Reza Shahriarirad
    BMC Endocrine Disorders.2023;[Epub]     CrossRef
  • Hashimoto’s Thyroiditis: A Protective Factor against Recurrence in BRAF-Wild Type Differentiated Thyroid Carcinoma
    Peter P. Issa, Mahmoud Omar, Yusef Buti, Mohamed Aboueisha, Ruhul Munshi, Mohammad Hussein, Muhib Haidari, Graham Blair, Chad P. Issa, Mohamed Shama, Eman Toraih, Emad Kandil
    Cancers.2023; 15(8): 2371.     CrossRef
  • VITAMIN D AND AUTOIMMUNE THYROIDITIS
    K. V. Pivtorak, O. V Ivanhuk O. V
    Bulletin of Problems Biology and Medicine.2023; 1(1): 44.     CrossRef
  • Does the Association of Hashimoto's Thyroiditis with Differentiated Thyroid Cancer Really Have a Protective Role?
    Ahmet Numan Demir, Zehra Kara, Cem Sulu, Serhat Uysal, Serdar Sahin, Guldana Zulfaliyeva, Oznur Aydin Atar, Nahida Valikhanova, Tulin Ozturk, Hande Mefkure Ozkaya, Mustafa Sait Gonen
    Hormone and Metabolic Research.2023; 55(06): 388.     CrossRef
  • Ultrasound, laboratory and histopathological insights in diagnosing papillary thyroid carcinoma in a paediatric population: a single centre follow-up study between 2000-2022
    Dominika Januś, Małgorzata Wójcik, Anna Taczanowska-Niemczuk, Aleksandra Kiszka-Wiłkojć, Monika Kujdowicz, Małgorzata Czogała, Wojciech Górecki, Jerzy B. Starzyk
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Early Post-operative Stimulated Serum Thyroglobulin: Role in Preventing Unnecessary Radioactive Iodine Treatment in Low to Intermediate Risk Papillary Thyroid Cancer
    Havva Sezer, Dilek Yazıcı, Tarık Terzioğlu, Serdar Tezelman, Hande Bulut Canbaz, Aslıhan Yerlikaya, Mehmet Onur Demirkol, Yersu Kapran, Bülent Çolakoğlu, Eda Nur Çilingiroğlu, Faruk Alagöl
    The American Surgeon™.2023; 89(12): 5996.     CrossRef
  • 2023 Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules
    Young Joo Park, Eun Kyung Lee, Young Shin Song, Soo Hwan Kang, Bon Seok Koo, Sun Wook Kim, Dong Gyu Na, Seung-Kuk Baek, So Won Oh, Min Kyoung Lee, Sang-Woo Lee, Young Ah Lee, Yong Sang Lee, Ji Ye Lee, Dong-Jun Lim, Leehi Joo, Yuh-Seog Jung, Chan Kwon Jung
    International Journal of Thyroidology.2023; 16(1): 1.     CrossRef
  • Clonal redemption of B cells in cancer
    Tyler R. McCaw, Serena Y. Lofftus, Joseph G. Crompton
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Prevalence and Impact of BRAF mutation in patients with concomitant papillary thyroid carcinoma and Hashimoto’s thyroiditis: a systematic review with meta-analysis
    Lukasz Janicki, Agastya Patel, Jarosław Jendrzejewski, Andrzej Hellmann
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis
    Nese E. GULCELIK, Safak AKIN, Kadriye AYDIN, Cisel AYDIN MERICOZ, Yesim G. GULER TEZEL, Aydan USMAN
    Minerva Endocrinology.2023;[Epub]     CrossRef
  • Chronic Lymphocytic Thyroiditis and Aggressiveness of Pediatric Differentiated Thyroid Cancer
    Richard M. Yeker, Amber D. Shaffer, Pushpa Viswanathan, Selma F. Witchel, Kevin Mollen, Linwah Yip, Sara E. Monaco, Umamaheswar Duvvuri, Jeffrey P. Simons
    The Laryngoscope.2022; 132(8): 1668.     CrossRef
  • Bisphenol A drives di(2-ethylhexyl) phthalate promoting thyroid tumorigenesis via regulating HDAC6/PTEN and c-MYC signaling
    Xuan Zhang, Nan Guo, Hao Jin, Renqi Liu, Zhen Zhang, Cheng Cheng, Zhijun Fan, Guopei Zhang, Mingyang Xiao, Shengwen Wu, Yuejiao Zhao, Xiaobo Lu
    Journal of Hazardous Materials.2022; 425: 127911.     CrossRef
  • Squamous Differentiation in the Thyroid: Metaplasia, Neoplasia, or Bystander?
    Meagan A. Chambers, Peter M. Sadow, Darcy A. Kerr
    International Journal of Surgical Pathology.2022; 30(4): 385.     CrossRef
  • Vitamin D Implications and Effect of Supplementation in Endocrine Disorders: Autoimmune Thyroid Disorders (Hashimoto’s Disease and Grave’s Disease), Diabetes Mellitus and Obesity
    Dorina Galușca, Mihaela Popoviciu, Emilia Babeș, Mădălina Vidican, Andreea Zaha, Vlad Babeș, Alexandru Jurca, Dana Zaha, Florian Bodog
    Medicina.2022; 58(2): 194.     CrossRef
  • Central Compartment Lymph Nodes Have Distinct Metastatic Patterns in Different Age Groups
    Caigu Yan, Xianghui He, Zuoyu Chen, Yizeng Wang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Synchronous occurrence of papillary thyroid microcarcinoma, medullary thyroid carcinoma and Hashimoto thyroiditis in a single thyroid
    Ari M. Abdullah, Rawa M. Ali, Karzan M. Salih, Karukh K. Mohammed, Fahmi H. Kakamad, Abdulwahid M. Salih
    International Journal of Surgery Case Reports.2022; 93(C): 106888.     CrossRef
  • Benign and malignant thyroid nodules with autoimmune thyroiditis
    Georgia N. Kassi, Catherine C. Evangelopoulou, Konstantinos D. Papapostolou, Helen J. Karga
    Archives of Endocrinology and Metabolism.2022;[Epub]     CrossRef
  • Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis
    Qizhi Tang, Weiyu Pan, Liangyue Peng, Francis Moore
    PLOS ONE.2022; 17(6): e0269995.     CrossRef
  • A Narrative Review of Preventive Central Lymph Node Dissection in Patients With Papillary Thyroid Cancer - A Necessity or an Excess
    David D. Dolidze, Alexey V. Shabunin, Robert B. Mumladze, Arshak V. Vardanyan, Serghei D. Covantsev, Alexander M. Shulutko, Vasiliy I. Semikov, Khalid M. Isaev, Airazat M. Kazaryan
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Role of papillary thyroid carcinoma patients with Hashimoto thyroiditis: evaluation of oxidative stress and inflammatory markers
    Natália Medeiros Dias Lopes, Hannah Hamada Mendonça Lens, Walison Augusto da Silva Brito, Julya Karen Bianchi, Poliana Camila Marinello, Rubens Cecchini, André Armani, Alessandra Lourenço Cecchini
    Clinical and Translational Oncology.2022; 24(12): 2366.     CrossRef
  • Emerging trends and hot spots in autoimmune thyroiditis research from 2000 to 2022: A bibliometric analysis
    Qiuxian Li, Wanyu Yang, Jiashu Li, Zhongyan Shan
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • The Immune Landscape of Papillary Thyroid Cancer in the Context of Autoimmune Thyroiditis
    Fabiana Pani, Paola Caria, Yoshinori Yasuda, Miyara Makoto, Stefano Mariotti, Laurence Leenhardt, Solmaz Roshanmehr, Patrizio Caturegli, Camille Buffet
    Cancers.2022; 14(17): 4287.     CrossRef
  • Comprehensive analysis of lncRNA-mediated ceRNA regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto’s thyroiditis
    Yuepeng Zhang, Yueli Tian
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • Elastographic Evaluation of Thyroid Nodules in Children and Adolescents with Hashimoto’s Thyroiditis and Nodular Goiter with Reference to Cytological and/or Histopathological Diagnosis
    Hanna Borysewicz-Sańczyk, Beata Sawicka, Filip Bossowski, Janusz Dzięcioł, Artur Bossowski
    Journal of Clinical Medicine.2022; 11(21): 6339.     CrossRef
  • Prognostic value of the preoperative and early trends in postoperative serum thyroglobulin antibody levels among patients with papillary thyroid carcinoma and concomitant Hashimoto’s thyroiditis
    Siyuan Xu, Hui Huang, Jiaxin Qian, Xiaolei Wang, Zhengang Xu, Shaoyan Liu, Jie Liu
    Endocrine.2022; 80(2): 392.     CrossRef
  • What has changed in the last 20 years in the postoperative specimen findings of the papillary thyroid cancer cases? A retrospective analysis
    Burak Bakar, Pınar Taşar, Turkay Kırdak, Sadık Kılıçturgay
    Turkish Journal of Surgery.2022; 38(4): 345.     CrossRef
  • A nomogram model based on the preoperative clinical characteristics of papillary thyroid carcinoma with Hashimoto's thyroiditis to predict central lymph node metastasis
    Wanjun Zhao, Linye He, Jingqiang Zhu, Anping Su
    Clinical Endocrinology.2021; 94(2): 310.     CrossRef
  • The Association of Histologically Proven Chronic Lymphocytic Thyroiditis with Clinicopathological Features, Lymph Node Metastasis, and Recurrence Rates of Differentiated Thyroid Cancer
    Berna İmge Aydoğan, Adile Begüm Bahçecioğlu Mutlu, Seher Yüksel, Sevim Güllü, Rıfat Emral, Özgür Demir, Mustafa Şahin, Vedia Tonyukuk Gedik, Demet Çorapçıoğlu, Serpil Dizbay Sak, Murat Faik Erdoğan
    Endocrine Pathology.2021; 32(2): 280.     CrossRef
  • Beneficial autoimmunity improves cancer prognosis
    Laurence Zitvogel, Claude Perreault, Olivera J. Finn, Guido Kroemer
    Nature Reviews Clinical Oncology.2021; 18(9): 591.     CrossRef
  • Influence Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: Hashimoto’s Thyroiditis Has a Weak Effect on Central or Lateral Lymph Node Metastasis
    Liguang Zhou, Gang Chen, Lei Sheng, Nan Liu, Bin Zhang, Qingdong Zeng, Bo Chen
    Cancer Management and Research.2021; Volume 13: 3953.     CrossRef
  • Implications of a background of Hashimoto’s thyroiditis on the current conservative surgical trend towards papillary thyroid carcinoma
    Shadi Hamouri, Sohail Bakkar, Almoutuz Aljaafreh, Mohammed Bani Hani, Hussein Heis, Ghazi Qasaimeh, Nasr Alrabadi, Wisam Al Gargaz, Haitham Odat, Yazan Alkurdi, Tarek Manasreh, Mohammad Matalka, Moamin Badwan
    Updates in Surgery.2021; 73(5): 1931.     CrossRef
  • Thyroid nodules in childhood‐onset Hashimoto's thyroiditis: Frequency, risk factors, follow‐up course and genetic alterations of thyroid cancer
    Yun Jeong Lee, Yeon Jin Cho, You Joung Heo, Eun‐Jae Chung, Young Hun Choi, Jong‐Il Kim, Young Joo Park, Choong Ho Shin, Young Ah Lee
    Clinical Endocrinology.2021; 95(4): 638.     CrossRef
  • Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes
    Siyuan Xu, Hui Huang, Jiaxin Qian, Yang Liu, Ying Huang, Xiaolei Wang, Shaoyan Liu, Zhengang Xu, Jie Liu
    JAMA Network Open.2021; 4(7): e2118526.     CrossRef
  • The Effects of Chronic Lymphocytic Thyroiditis on Clinicopathologic Factors in Papillary Thyroid Cancer
    Davut Sakiz, Muhammed Erkam Sencar, Murat Calapkulu, Ilknur Ozturk Unsal, Levent Aktas, Bekir Ucan, Mustafa Ozbek, Erman Cakal
    Endocrine Practice.2021; 27(12): 1199.     CrossRef
  • Significance of DMBT1 in Papillary Thyroid Carcinoma Concurrent With Hashimoto’s Thyroiditis
    Xiao-xiong Gan, Ya-yi Li, Si-jin Li, Shi-sen Mo, Jian-hua Feng, Fei Shen, Wen-song Cai, Ye-qian Lai, Bo Xu
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Pre-existing Thyroiditis Ameliorates Papillary Thyroid Cancer: Insights From a New Mouse Model
    Fabiana Pani, Yoshinori Yasuda, Giulia Di Dalmazi, Paulina Chalan, Kathleen Gabrielson, Luigi Adamo, Elena Sabini, Stefano Mariotti, Patrizio Caturegli
    Endocrinology.2021;[Epub]     CrossRef
  • Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma
    Juliette Paillet, Céleste Plantureux, Sarah Lévesque, Julie Le Naour, Gautier Stoll, Allan Sauvat, Pamela Caudana, Jimena Tosello Boari, Norma Bloy, Sylvie Lachkar, Isabelle Martins, Paule Opolon, Andrea Checcoli, Agathe Delaune, Noémie Robil, Pierre de l
    Journal of Experimental Medicine.2021;[Epub]     CrossRef
  • Papillary Thyroid Cancer Prognosis: An Evolving Field
    Salvatore Ulisse, Enke Baldini, Augusto Lauro, Daniele Pironi, Domenico Tripodi, Eleonora Lori, Iulia Catalina Ferent, Maria Ida Amabile, Antonio Catania, Filippo Maria Di Matteo, Flavio Forte, Alberto Santoro, Piergaspare Palumbo, Vito D’Andrea, Salvator
    Cancers.2021; 13(21): 5567.     CrossRef
  • Overexpression of PD-L1 in Papillary Carcinoma and Its Association with Clinicopathological Variables
    Servet KOCAÖZ, Gülay TURAN
    Düzce Tıp Fakültesi Dergisi.2021; 23(3): 252.     CrossRef
  • Correlation Between Hashimoto's Thyroiditis–Related Thyroid Hormone Levels and 25-Hydroxyvitamin D
    Guanqun Chao, Yue Zhu, Lizheng Fang
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma
    Dongbin Ahn, Gil J. Lee, Jin H. Sohn, Jae H. Jeon
    Head & Neck.2020; 42(5): 1004.     CrossRef
  • Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1
    Li Jianming, Liu Jibin, Qian Linxue
    European Journal of Radiology.2020; 123: 108801.     CrossRef
  • Unexpected high‐risk pathologic features following thyroidectomy in the chinese immigrant population
    Arvind K. Badhey, Erin Moshier, Ameya Jategaonkar, Anni Wong, Kristen Echanique, Raymond L. Chai
    The Laryngoscope.2020; 130(7): 1844.     CrossRef
  • Hashimoto's thyroiditis attenuates progression of papillary thyroid carcinoma: deciphering immunological links
    Oksana Sulaieva, Oleksii Selezniov, Dmytro Shapochka, Nataliia Belemets, Oleksandr Nechay, Yelizaveta Chereshneva, Dibakhan Tsomartova, Marina Ivanova
    Heliyon.2020; 6(1): e03077.     CrossRef
  • Changes in Treg numbers and activity in papillary thyroid carcinoma with and without Hashimoto’s thyroiditis
    Na Zhao, Xin Liu, Chao Wu, Yuanchao Liu, Xiangnan Zhao, Xianghui He
    Journal of International Medical Research.2020;[Epub]     CrossRef
  • Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis
    Ohoud Subhi, Hans-Juergen Schulten, Nadia Bagatian, Roa'a Al-Dayini, Sajjad Karim, Sherin Bakhashab, Reem Alotibi, Alaa Al-Ahmadi, Manar Ata, Aisha Elaimi, Saad Al-Muhayawi, Majid Mansouri, Khalid Al-Ghamdi, Osman Abdel Hamour, Awatif Jamal, Jaudah Al-Mag
    PLOS ONE.2020; 15(6): e0234566.     CrossRef
  • Hashimoto's thyroiditis as a risk factor for thyroid cancer
    Ulla Feldt-Rasmussen
    Current Opinion in Endocrinology, Diabetes & Obesity.2020; 27(5): 364.     CrossRef
  • Predictive Factors of Recurrence for Multifocal Papillary Thyroid Microcarcinoma With Brafv600e Mutation: A Single Center Study of 1,207 Chinese Patients
    Shuai Xue, Li Zhang, Peisong Wang, Jia Liu, Yue Yin, Meishan Jin, Liang Guo, Yuhua Zhou, Guang Chen
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy
    Francesca Ragusa, Poupak Fallahi, Giusy Elia, Debora Gonnella, Sabrina Rosaria Paparo, Claudia Giusti, Leonid P. Churilov, Silvia Martina Ferrari, Alessandro Antonelli
    Best Practice & Research Clinical Endocrinology & Metabolism.2019; 33(6): 101367.     CrossRef
  • Características anatomopatológicas del carcinoma papilar de tiroides en especimenes con y sin tiroiditis linfocitica crónica.
    Carlos Osorio Covo, Jorge Ballestas Barrera, Jorge Martínez Castro, Zully Acevedo Meza, Diego Barrios Castellar, Francisco Herrera Sáenz, Cesar Redondo Bermúdez, Katherine Redondo De Oro
    Revista Ciencias Biomédicas.2019; 8(2): 32.     CrossRef
Close layer
Case Reports
Partial Androgen Insensitivity Syndrome Presenting with Gynecomastia
Sung Won Lee, Dong Shin Kwak, In Sub Jung, Joo Hee Kwak, Jung Hwan Park, Sang Mo Hong, Chang Bum Lee, Yong Soo Park, Dong Sun Kim, Woong Hwan Choi, You Hern Ahn
Endocrinol Metab. 2015;30(2):226-230.   Published online June 30, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.2.226
  • 19,834 View
  • 109 Download
  • 9 Web of Science
  • 10 Crossref
AbstractAbstract PDFPubReader   

Gynecomastia is a benign enlargement of the male breast caused by the proliferation of glandular breast tissue. Determining the various causes of gynecomastia such as physiological causes, drugs, systemic diseases, and endocrine disorders is important. Androgen insensitivity syndrome (AIS) is a rare endocrine disorder presenting with gynecomastia and is a disorder of male sexual differentiation caused by mutations within the androgen receptor gene. All individuals with AIS have the 46 XY karyotype, although AIS phenotypes can be classified as mild, partial or complete and can differ among both males and females including ambiguous genitalia or infertility in males. We experienced a case of partial AIS presenting with gynecomastia and identified the androgen receptor gene mutation.

Citations

Citations to this article as recorded by  
  • Management of gynecomastia in adolescence and adults: the clinical practice guidelines from the Italian Society of Andrology and Sexual Medicine (SIAMS)
    Carlotta Pozza, Riccardo Selice, Arcangelo Barbonetti, Valeria Hasenmajer, Francesco Lotti, Davide Menafra, Daniela Pasquali, Andrea Sansone, Andrea M. Isidori, Vincenzo Rochira
    Journal of Endocrinological Investigation.2026;[Epub]     CrossRef
  • Case Report: Laparoscopic vaginoplasty in a case of partial androgen insensitivity syndrome and a literature review of 16 cases in China
    Haixia Qin, Huaqian Liu, Qiang Liu, Baiou Li
    Frontiers in Surgery.2025;[Epub]     CrossRef
  • A case of mild partial androgen insensitivity syndrome in a juvenile boy
    Fen Wang, Shiying Shao, Wentao He, Shuhong Hu
    Journal of International Medical Research.2024;[Epub]     CrossRef
  • Gynecomastia in adolescent males: current understanding of its etiology, pathophysiology, diagnosis, and treatment
    Kotb Abbass Metwalley, Hekma Saad Farghaly
    Annals of Pediatric Endocrinology & Metabolism.2024; 29(2): 75.     CrossRef
  • Satisfaction and results of the subareolar incision as treatment for gynecomastia in adolescents: experience of two centers
    Andrea Zangari, Carmine Noviello, Camilla Todesco, Mercedes Romano, Letizia Trotta, Carmine Botta, Ilaria Cascone, Salvatore Scommegna, Gabriele Vasta, Vito Briganti, Alfonso Papparella
    La Pediatria Medica e Chirurgica.2024;[Epub]     CrossRef
  • Clinical outcomes and genotype-phenotype correlations in patients with complete and partial androgen insensitivity syndromes
    Nae-yun Lee, Ja Hye Kim, Ji-Hee Yoon, Soojin Hwang, Gu-Hwan Kim, Han-Wook Yoo, Jin-Ho Choi
    Annals of Pediatric Endocrinology & Metabolism.2023; 28(3): 184.     CrossRef
  • The Impact and Management of Gynaecomastia in Klinefelter Syndrome
    Amr Abdel Raheem, Ahmed Said Zaghloul, Ahmed M. G. Sadek, Bilal Rayes, Tarek M. Abdel-Raheem
    Frontiers in Reproductive Health.2021;[Epub]     CrossRef
  • Identification of Potential Genes in Pathogenesis and Diagnostic Value Analysis of Partial Androgen Insensitivity Syndrome Using Bioinformatics Analysis
    Yajie Peng, Hui Zhu, Bing Han, Yue Xu, Xuemeng Liu, Huaidong Song, Jie Qiao
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Adolescent Gynecomastia due to Minimal Androgen Resistance Syndrome: A Case Report and Literature Review
    Aureliano Fiorini, Margherita Sepich, Margherita Pontrelli, Giorgio Sangriso, Mirna Cosci o Di Coscio, Marcella Lauletta, Fulvia Baldinotti, Diego Peroni, Maria Rosaria Ambrosio, Silvano Bertelloni
    Sexual Development.2020; 14(1-6): 21.     CrossRef
  • Endocrine and molecular investigations in a cohort of 25 adolescent males with prominent/persistent pubertal gynecomastia
    F. Paris, L. Gaspari, F. Mbou, P. Philibert, F. Audran, Y. Morel, A. Biason‐Lauber, C. Sultan
    Andrology.2016; 4(2): 263.     CrossRef
Close layer
Thyroid
A Case of Acute Suppurative Thyroiditis with Thyrotoxicosis in an Elderly Patient
Bo Sang Kim, Kil Woo Nam, Jeong Eun Kim, Ji Hoon Park, Jun Sik Yoon, Jung Hwan Park, Sang Mo Hong, Chang Bum Lee, Yong Soo Park, Woong Hwan Choi, You Hern Ahn, Dong Sun Kim
Endocrinol Metab. 2013;28(1):50-54.   Published online March 25, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.1.50
  • 11,797 View
  • 63 Download
  • 6 Crossref
AbstractAbstract PDFPubReader   

Acute suppurative thyroiditis (AST) is a rare condition, as the thyroid gland is relatively resistant to infection. Thyroid function tests are usually normal in AST. A few cases of AST associated with thyrotoxicosis have been reported in adults. We report a case of AST that was associated with thyrotoxicosis in a 70-year-old woman. We diagnosed AST with thyroid ultrasonography and fine needle aspiration of pus. The patient improved after surgical intervention and had no anatomical abnormality. Fine needle aspiration is the best method for the difficult task of differentiating malignancy and subacute thyroiditis from AST with thyrotoxicosis. Earlier diagnosis and proper treatment for AST might improve the outcome.

Citations

Citations to this article as recorded by  
  • Ultrasonographic Findings of Thyroid Parenchymal Disease
    Sung-Woo Kim
    Clinical Ultrasound.2024; 9(1): 25.     CrossRef
  • Acute suppurative thyroiditis with Graves disease – A very rare association
    Inês Damásio, Joana Maciel, Maria Manuel Costa, Luisa Raimundo
    Archives of Endocrinology and Metabolism.2023;[Epub]     CrossRef
  • Thyrotoxicosis as a rare presentation in acute suppurative thyroiditis: a case report
    Zeynab Seyedjavadeyn, Seyed Amir Miratashi Yazdi, Alireza Samimiat, Matin Vahedi
    Journal of Medical Case Reports.2023;[Epub]     CrossRef
  • Subakute Thyreoiditis und akute suppurative Thyreoiditis
    Christian Trummer, Verena Theiler-Schwetz, Stefan Pilz
    Journal für Klinische Endokrinologie und Stoffwechsel.2020; 13(3): 124.     CrossRef
  • Infection of Thyroid Cyst Occurring 1 Month after Fine-Needle Aspiration in an Immunocompetent Patient
    Jung Kyu Park, Eon Ju Jeon
    International Journal of Thyroidology.2018; 11(2): 182.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP